snsinsider 님의 블로그

The MRNA Therapeutics Contract Development & Manufacturing Market was valued at USD 3.12 billion in 2023 and is projected to reach USD 8.09 billion by 2032, expanding at a CAGR of 11.18% during the forecast period 2024-2032. The market growth is primarily driven by the rising adoption of mRNA-based therapeutics, increasing outsourcing by pharmaceutical companies, and advancements in bioprocessin..

The Cell And Gene Therapy Clinical Trials Market was valued at USD 9.48 billion in 2023 and is projected to witness exponential growth, reaching USD 32.96 billion by 2032, at a CAGR of 14.87% over the forecast period 2024-2032. This surge is attributed to increasing research and development (R&D) in regenerative medicine, rising prevalence of genetic disorders, and expanding clinical trials focu..

The Empty Capsules Market was valued at USD 3.35 billion in 2023 and is projected to reach USD 5.36 billion by 2032, growing at a CAGR of 5.37% during the forecast period 2024-2032. The market's expansion is driven by increasing demand from the pharmaceutical, nutraceutical, and dietary supplement industries, as well as growing awareness regarding the benefits of encapsulated drugs and supplemen..

The Clinical Trial Equipment & Ancillary Solutions Market was valued at USD 2.23 billion in 2023 and is expected to reach USD 4.39 billion by 2032, expanding at a CAGR of 7.84% over the forecast period 2024-2032. The market’s growth is being fueled by the increasing number of clinical trials worldwide, advancements in trial technologies, and the rising trend of outsourcing clinical research to c..

The Arthroscopy Market was valued at USD 6.23 billion in 2023 and is projected to reach USD 8.66 billion by 2032, growing at a CAGR of 3.76% over the forecast period from 2024 to 2032. The market is experiencing steady growth due to the rising number of sports-related injuries, an aging population suffering from osteoarthritis, and increasing demand for minimally invasive surgical procedures tha..

The Electronic Clinical Outcome Assessment (eCOA) Solutions Market was valued at USD 1.57 billion in 2023 and is projected to reach USD 5.64 billion by 2032, growing at a CAGR of 15.3% over the forecast period from 2024 to 2032. The increasing digitization of healthcare, the need for efficient clinical trial management, and regulatory requirements emphasizing patient-centric outcomes are some of..

The AI in Precision Medicine Market was valued at USD 1.80 billion in 2023 and is projected to experience exponential growth, reaching USD 18.27 billion by 2032. This remarkable expansion, at a CAGR of 29.37% from 2024 to 2032, is fueled by the rapid integration of artificial intelligence (AI) in precision medicine, enhanced data analytics capabilities, and an increasing emphasis on personalized..

The Healthcare Testing, Inspection, and Certification Outsourcing Market was valued at USD 4.96 billion in 2023 and is projected to reach USD 10.53 billion by 2032, growing at a CAGR of 8.74% over the forecast period from 2024 to 2032. The increasing complexity of healthcare regulations, rising demand for medical device and pharmaceutical testing, and growing emphasis on patient safety and produ..

The Animal Parasiticides Market was valued at USD 10.80 billion in 2023 and is projected to reach USD 18.71 billion by 2032, growing at a CAGR of 6.32% during the forecast period 2024-2032. The increasing prevalence of parasitic infections in pets and livestock, rising pet adoption rates, and the expansion of the global animal healthcare industry are key factors driving market growth. Additional..

The Clinical Trial Supplies Market was valued at USD 2.47 billion in 2023 and is projected to reach USD 4.62 billion by 2032, registering a CAGR of 7.20% over the forecast period from 2024 to 2032. The market's rapid expansion is attributed to the rising number of clinical trials, increased R&D investments by pharmaceutical and biotechnology companies, and advancements in logistics and supply ch..